Wilms Tumour

Overview

Nephroblastoma = embryonic tumour, primitive renal epithelial+mesenchymal components. COMMONEST abdominal malignancy in young children, 1-6yr, equal sex incidence.

Etiology/pathogenesis

Associations: monozygotic twins, family history, congenital anomalies (esp. GU tract), other childhood malignancies (osteosarcoma, botryoid sarcoma, retinoblastoma, neuroblastoma).

Genetics:

WT1 gene (chr 11p13) — normal: kidney/gonad development protein. Deletion → WAGR syndrome (Wilms tumour+Aniridia+Genitourinary anomalies+mental Retardation) — missing one WT1 copy per cell → predisposes Wilms + other cancers
Gonadal dysgenesis — shared mutation → ↑Wilms risk
β-catenin/WNT pathway synergism — sporadic cases

Morphology

Gross: large, spheroidal, replaces most of kidney. Solitary/unilateral mostly (5-10% bilateral). VARIEGATED cut surface — soft, fishflesh-like, grey-white to cream-yellow, necrosis/haemorrhage, grossly visible MYXOMATOUS/CARTILAGINOUS elements. Renal vein invasion grossly evident in ~half.

Micro: mixture of primitive EPITHELIAL+MESENCHYMAL elements. Mostly small round-spindled anaplastic sarcomatoid cells + abortive tubules/poorly-formed glomeruli. Mesenchymal elements: smooth/skeletal muscle, cartilage, bone, fat, fibrous tissue — reflects origin from primitive multipotent metanephric blastema.

Clinical features

Commonest presentation: palpable abdominal mass in child. Also haematuria, pain, fever, HTN. Rapid haematogenous spread, esp. LUNGS.

Prognosis: dramatically improved with combo therapy (nephrectomy+radiation+chemo) — 5yr survival now 80-90%.

Clinical relevance

Mixed epithelial-mesenchymal morphology directly reflects origin from primitive metanephric blastema — normally differentiates into full range of renal epithelial+stromal elements, tumour recapitulates that developmental versatility in disorganised neoplastic form. WAGR syndrome = instructive contiguous gene deletion example — WT1 deletion (11p13) sits near PAX6 gene (iris development) → ONE chromosomal deletion → both tumour predisposition AND unrelated-seeming aniridia — aniridia in a child should prompt Wilms surveillance. Dramatic prognosis improvement (80-90% 5yr survival) = paediatric oncology success story — chemo/radiosensitivity + surgical resectability = genuinely curative in majority. Renal vein invasion in ~half of cases (comparable to RCC despite totally different cell of origin — mature tubular epithelium vs primitive blastema) — vascular invasion tendency doesn’t track with differentiation degree.

Overview

Wilms’ tumour (nephroblastoma) is an embryonic tumour derived from primitive renal epithelial and mesenchymal components — the most common abdominal malignant tumour of young children, typically 1–6 years, equal sex incidence.

Etiology and Pathogenesis

Associations: higher incidence in monozygotic twins and familial cases; association with congenital anomalies (especially genitourinary tract); higher co-incidence with other childhood malignancies (osteosarcoma, botryoid sarcoma, retinoblastoma, neuroblastoma).

Genetic pathogenesis:

WT1 gene (chromosome 11p13) — normally directs kidney/gonad developmental protein synthesis. Deletion produces WAGR syndrome (Wilms tumour, Aniridia, Genitourinary anomalies, mental Retardation) — affected individuals are missing one WT1 copy in every cell, predisposing to Wilms’ tumour and several other cancers.
Gonadal dysgenesis — shared genetic mutation raises Wilms’ tumour risk in these patients too.
β-catenin/WNT pathway synergism — a molecular mechanism implicated in sporadic cases, via a shared mutation across these two signalling pathways.

Morphology

Gross: usually large, spheroidal, replacing most of the kidney; solitary and unilateral in most cases (5–10% bilateral). Cut surface has a characteristic variegated appearance — soft, fishflesh-like, grey-white to cream-yellow, with necrosis, haemorrhage, and grossly visible myxomatous or cartilaginous elements. Renal vein invasion is grossly evident in about half of cases.

Micro: a genuine mixture of primitive epithelial and mesenchymal elements — most of the tumour is small, round-to-spindled, anaplastic, sarcomatoid cells, among which abortive tubules and poorly-formed glomerular structures appear. Mesenchymal elements can include smooth/skeletal muscle, cartilage, bone, fat, fibrous tissue — reflecting the tumour’s origin from primitive, multipotent metanephric blastema capable of differentiating along multiple embryonic renal lineages simultaneously.

Clinical Features

Most common presentation: a palpable abdominal mass in a child. Also haematuria, pain, fever, hypertension. Spreads rapidly via blood, especially to the lungs.

Prognosis: dramatically improved with combination therapy (nephrectomy + postoperative irradiation + chemotherapy) — 5-year survival now 80–90%, a striking contrast to most other aggressive childhood malignancies.

Clinical Relevance

Wilms’ tumour’s mixed epithelial-mesenchymal morphology (abortive tubules/glomeruli embedded among diverse mesenchymal tissue types) directly reflects its origin from primitive metanephric blastema — a cell population that normally differentiates into the full range of renal epithelial and stromal elements, so the tumour recapitulates that same developmental versatility in a disorganised, neoplastic form.
WAGR syndrome is a genuinely instructive example of a contiguous gene deletion syndrome — the WT1 deletion on 11p13 sits near the PAX6 gene (responsible for iris development), so a single chromosomal deletion produces both the tumour predisposition and the unrelated-seeming aniridia finding, which is why aniridia in a child should prompt specific surveillance for Wilms’ tumour.
The dramatic prognosis improvement in Wilms’ tumour (80–90% 5-year survival with modern combination therapy) stands in sharp contrast to many other malignancies and is worth remembering specifically as a paediatric oncology success story — the tumour’s chemo- and radiosensitivity, combined with surgical resectability, make aggressive multimodal treatment genuinely curative in the large majority of cases.
Recognising renal vein invasion as grossly evident in about half of cases — comparable in frequency to the vascular invasion seen in renal cell carcinoma (see Renal Cell Carcinoma) despite the two tumours arising from completely different cells of origin (mature tubular epithelium versus primitive blastema) — is a useful reminder that vascular invasion tendency doesn’t necessarily track with a tumour’s degree of differentiation.